IDIBELL Cancer Conference (ICC) on Personalized Cancer Medicine  will be held at the Hesperia Tower Hotel, L'Hospitalet de Llobregat, Barcelona from December 3rd to 4th, 2012. Guest speakers are leading scientists in the field of Oncology and Cancer Research, particularly in the study of genetic and epigenetic defects leading to the selection of cancer patients for new therapeutic drugs. The goal of this meeting is to highlight the latest advances in the biological mechanisms and the natural history of cancer that provides novel targets for therapy, as well as to discuss in depth the molecular mechanisms involved in the stratification of oncology patents according to the recently described molecular markers. The conference which lasts for two full days will bring together a selected group of twenty-one speakers and a maximum of two hundred and fifty participants. Special focus will be devoted to Epigenetics and DNA Repair and the Metabolism and Cell Signalling areas with the updated clinical applications.

Moreover, applicants are encouraged to submit abstracts for poster presentations. Four of these abstracts will be selected for oral communication.